These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate/severe cellulitis. Ibrahim LF; Hopper SM; Connell TG; Daley AJ; Bryant PA; Babl FE Emerg Med J; 2017 Dec; 34(12):780-785. PubMed ID: 28978652 [TBL] [Abstract][Full Text] [Related]
26. Antimicrobial therapy for serious bacterial infections in children in a primary care setting--a poll of experts. Zar HJ; Hussey G S Afr Med J; 1999 Jul; 89(7):739-41. PubMed ID: 10470305 [No Abstract] [Full Text] [Related]
27. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy. Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221 [TBL] [Abstract][Full Text] [Related]
28. Ambulatory intravenous ceftriaxone in paediatric A&E: a useful alternative to hospital admission? Smith JK; Alexander S; Abrahamson E Emerg Med J; 2011 Oct; 28(10):877-81. PubMed ID: 21325012 [TBL] [Abstract][Full Text] [Related]
29. Outpatient treatment of serious infections in infants and children with ceftriaxone. Powell KR; Mawhorter SD J Pediatr; 1987 Jun; 110(6):898-901. PubMed ID: 3585606 [No Abstract] [Full Text] [Related]
30. Treatment of acute pyelonephritis in women with intramuscular ceftriaxone: an out-patient study. Karachalios GN; Georgiopoulos AN; Kintziou H Chemotherapy; 1991; 37(4):292-6. PubMed ID: 1790728 [TBL] [Abstract][Full Text] [Related]
31. Ceftriaxone, a third generation cephalosporin. Johnson ES; Fedder M; Smith LG J Med Soc N J; 1984 Nov; 81(11):941-4. PubMed ID: 6096548 [No Abstract] [Full Text] [Related]
32. Management and complications of bacterial periorbital and orbital cellulitis. Newell FW; Leveille AS Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):209-14. PubMed ID: 7185014 [TBL] [Abstract][Full Text] [Related]
33. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group. Barnett ED; Teele DW; Klein JO; Cabral HJ; Kharasch SJ Pediatrics; 1997 Jan; 99(1):23-8. PubMed ID: 8989332 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer. Pession A; Prete A; Paolucci G Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370 [TBL] [Abstract][Full Text] [Related]
35. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. Schaad UB; Suter S; Gianella-Borradori A; Pfenninger J; Auckenthaler R; Bernath O; Cheseaux JJ; Wedgwood J N Engl J Med; 1990 Jan; 322(3):141-7. PubMed ID: 2403654 [TBL] [Abstract][Full Text] [Related]
36. Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages. Esposito S Drugs; 2000; 59 Suppl 3():19-28; discussion 47-9. PubMed ID: 10845410 [TBL] [Abstract][Full Text] [Related]
37. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073 [TBL] [Abstract][Full Text] [Related]
38. Outpatient parenteral antibiotic therapy. Management of serious infections. Part II: Amenable infections and models for delivery. Cellulitis. Lindbeck G; Powers R Hosp Pract (Off Ed); 1993 Jul; 28 Suppl 2():10-4; discussion 57. PubMed ID: 8325921 [TBL] [Abstract][Full Text] [Related]
39. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections. Plosker GL; Foster RH; Benfield P Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990 [TBL] [Abstract][Full Text] [Related]